Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06719583 · ClinicalTrials.gov registry record
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
A clinical trial of Parkinson Disease, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 12
- Study locations
NCT06719583 is a study of Parkinson Disease that is actively recruiting participants, run by Michael J. Fox Foundation for Parkinson's Research. The registered enrollment target is 2,000 participants, below the 5,320-participant average among 297 other Parkinson Disease trials with a reported enrollment target (62% lower). The trial reports 12 study locations across 9 states.
The verdict
NCT06719583, a study of Parkinson Disease, is actively recruiting participants, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 12
- Study locations
Study Summary
BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities. BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of the genetics of Parkinson's disease and make that knowledge globally relevant.
Conditions Studied
Study Locations (12)
Illinois
- Rush University - Chicago
- University of Chicago - Chicago
Louisiana
- Ochsner Clinic Foundation - New Orleans
- Louisiana State University Health Sciences Center Shreveport - Shreveport
Maryland
- University of Maryland - Baltimore
- Kaiser Permanente Midatlantic States - Rockville
Alabama
- University of Alabama at Birmingham - Birmingham
Florida
- University of Florida - Gainesville
Missouri
- Washington University in St. Louis - St Louis
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06719583
The ClinicalTrials.gov registry entry for NCT06719583 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,320-participant average among 297 other Parkinson Disease trials with a reported enrollment target (62% lower). The listed sponsor is Michael J. Fox Foundation for Parkinson's Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT06719583 reports 12 study locations spanning 9 distinct geographic areas - top geographies include Illinois, Louisiana, Maryland.
Frequently Asked Questions
What is clinical trial NCT06719583 about?
NCT06719583 is a clinical study titled "Black and African Americans Connections to Parkinson's Disease (BLAAC PD)". BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities. BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to tra...
What is the current status of trial NCT06719583?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2020-11-16. Estimated completion is 2027-12-31.
What conditions does trial NCT06719583 study?
This clinical trial studies the following conditions: Parkinson Disease.
Who is sponsoring clinical trial NCT06719583?
This trial is sponsored by Michael J. Fox Foundation for Parkinson's Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06719583 being conducted?
This trial has 12 study locations across Alabama, Florida, Illinois, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.